{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-013620","form_type":"8-K","ticker":"FEED","cik":"0001326706","company_name":"ENvue Medical, Inc.","filed_at":"2025-06-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.940672+00:00","generated_at":"2026-05-19T23:42:46.299046+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"NanoVibronix appoints Doron Besser as CEO; Brian Murphy retires but stays on board","bullets":["Brian Murphy retired as CEO of NanoVibronix effective June 4, 2025, and will remain as a director.","Doron Besser, previously CEO of subsidiary ENvue Medical Holdings, appointed as CEO effective same date.","NanoVibronix completed acquisition of ENvue on February 14, 2025, creating a combined growth platform.","Besser has a medical device background; previously helped lead superDimension, acquired by Covidien for ~$300M.","Board Chairman Christopher Fashek thanked Murphy and expressed confidence in Besser's leadership."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-013620","json":"https://secwatch.observer/filing/0001641172-25-013620.json","markdown":"https://secwatch.observer/filing/0001641172-25-013620.md","text":"https://secwatch.observer/filing/0001641172-25-013620.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326706/000164117225013620/0001641172-25-013620-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326706/000164117225013620/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T23:42:46.299046+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a30e9c5403","claim":"Doron Besser was appointed as Chief Executive Officer at ENvue Medical, Inc..","evidence_excerpt":"the Board of Directors (the “ Board ”) of NanoVibronix, Inc. (the “ Company ”) appointed Doron Besser, M.D., a director of the Board and Chief Executive Officer and President of the Company’s wholly-owned subsidiary, ENvue Medical Holdings LLC (“ ENvue ”), as the Company’s Chief Executive Officer (“ CEO ”), effective as of the same date","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1326706/000164117225013620/0001641172-25-013620-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"fdb827bb82","claim":"Brian Murphy resigned as Chief Executive Officer at ENvue Medical, Inc..","evidence_excerpt":"Brian Murphy resigned from the Company as its CEO due to Mr. Murphy’s retirement, effective as of the same date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1326706/000164117225013620/0001641172-25-013620-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}